Cumberland Pharmaceuticals Reports 9% Revenue Growth In 2020
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Cumberland Pharmaceuticals (CPIX) Tops Q4 EPS by 2c, Revenues Beat
March 9, 2021 4:23 PM ESTCumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.01, $0.02 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $10.26 million versus the consensus estimate of $9.78 million.
"We are grateful that Cumberland was able to successfully manage through the pandemic during 2020,... More
